Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease

Human T cell responses to Japanese encephalitis virus in health and disease

(2016) Lance Turtle et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Comparison of the live-attenuated Japanese encephalitis vaccine SA14 -14-2 strain with its pre-attenuated virulent parent SA14 strain: similarities and differences in vitro and in vivo

(2016) Sang-Im Yun et al.   JOURNAL OF GENERAL VIROLOGY

Persistence of Wild-Type Japanese Encephalitis Virus Strains Cross-Neutralization Five Years following JE-CV Immunization

(2016) Emmanuel Feroldi et al.   JOURNAL OF INFECTIOUS DISEASES

Immunogenicity and Safety of a Booster Dose of a Live Attenuated Japanese Encephalitis Chimeric Vaccine Given 1 Year After Primary Immunization in Healthy Children in the Republic of Korea

(2016) Dong Soo Kim et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children

(2016) Pakpoom Janewongwirot et al.   VACCINE

Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine

(2016) Pushpa Ranjan Wijesinghe et al.   VACCINE

Sero-Molecular Epidemiology of Japanese Encephalitis in Zhejiang, an Eastern Province of China

(2016) Jin-ren Pan et al.   PLoS Neglected Tropical Diseases

Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus

(2016) Lei Cao et al.   PLoS Neglected Tropical Diseases

Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity

(2016) Kuan Rong Chan et al.   Nature Microbiology

Prevalence of Neutralizing Antibodies to Japanese Encephalitis Virus among High-Risk Age Groups in South Korea, 2010

(2016) Eun Ju Lee et al.   PLoS One

Genetic and Phenotypic Properties of Vero Cell-Adapted Japanese Encephalitis Virus SA14-14-2 Vaccine Strain Variants and a Recombinant Clone, Which Demonstrates Attenuation and Immunogenicity in Mice

(2015) Gregory D. Gromowski et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Safety and immunogenicity of a freeze-dried, Vero cell culture-derived, inactivated Japanese encephalitis vaccine (KD-287, ENCEVAC®) versus a mouse brain-derived inactivated Japanese encephalitis vaccine in children: a phase III, multicenter, double-blinded, randomized trial

(2015) Ki Wook Yun et al.   BMC INFECTIOUS DISEASES

The A66G back mutation in NS2A of JEV SA 14 -14-2 strain contributes to production of NS1′ protein and the secreted NS1′ can be used for diagnostic biomarker for virulent virus infection

(2015) Jingman Wang et al.   INFECTION GENETICS AND EVOLUTION

A Japanese Encephalitis Vaccine From India Induces Durable and Cross-protective Immunity Against Temporally and Spatially Wide-ranging Global Field Strains

(2015) Anit Singh et al.   JOURNAL OF INFECTIOUS DISEASES

The Immunogenicity and Safety of the Live-attenuated SA 14-14-2 Japanese Encephalitis Vaccine Given with a Two-dose Primary Schedule in Children

(2015) Hyo Jin Kwon et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Profiling of Viral Proteins Expressed from the Genomic RNA of Japanese Encephalitis Virus Using a Panel of 15 Region-Specific Polyclonal Rabbit Antisera: Implications for Viral Gene Expression

(2015) Jin-Kyoung Kim et al.   PLoS One

Dengue viruses cluster antigenically but not as discrete serotypes

(2015) L. C. Katzelnick et al.   SCIENCE

Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis

(2015) Maria Paulke-Korinek et al.   VACCINE

Molecular epidemiology of Japanese encephalitis in northern Vietnam, 1964–2011: genotype replacement

(2015) Loan Phuong Do et al.   Virology Journal

Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysis

(2015) Shi-Yuan Wang et al.   Human Vaccines & Immunotherapeutics

Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from South-East Asia and India

(2014) Matthew Bonaparte et al.   BMC INFECTIOUS DISEASES

Changes in acute encephalitis syndrome incidence after introduction of Japanese encephalitis vaccine in a region of India

(2014) Prashant Ranjan et al.   JOURNAL OF INFECTION

Low coverage and acceptable effectiveness of single dose of Japanese encephalitis vaccine, Gorakhpur division, Uttar Pradesh, India, 2013

(2014) Manoj V. Murhekar et al.   JOURNAL OF INFECTION

Immunogenicity of single-dose Vero cell-derived Japanese encephalitis vaccine in Japanese adults

(2014) Nozomi Takeshita et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Comparison of Genotypes I and III in Japanese Encephalitis Virus Reveals Distinct Differences in Their Genetic and Host Diversity

(2014) N. Han et al.   JOURNAL OF VIROLOGY

Primary Immunization of Infants and Toddlers in Thailand with Japanese Encephalitis Chimeric Virus Vaccine in Comparison with SA14-14-2

(2014) Emmanuel Feroldi et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

A Spatial and Temporal Analysis of Japanese Encephalitis in Mainland China, 1963–1975: A Period without Japanese Encephalitis Vaccination

(2014) Xiaolong Li et al.   PLoS One

Safety of Japanese encephalitis live attenuated vaccination in post-marketing surveillance in Guangdong, China, 2005–2012

(2014) Yu Liu et al.   VACCINE

Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2

(2014) Dong Yang et al.   VACCINE

A cohort event monitoring to determine the adverse events following administration of mouse brain derived, inactivated Japanese Encephalitis vaccine in an endemic district in Sri Lanka

(2014) De Alwis K.N.L.S.K. et al.   VACCINE

Coupling of replication and assembly in flaviviruses

(2014) Swapna Apte-Sengupta et al.   Current Opinion in Virology

Reduction of neutralization antibody against heterologous circulating strains in adults immunized with Japanese encephalitis live vaccine

(2014) Qing Ye et al.   Human Vaccines & Immunotherapeutics

A randomized study of the immunogenicity and safety of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in comparison with SA14-14-2 Vaccine in children in the Republic of Korea

(2014) Dong Soo Kim et al.   Human Vaccines & Immunotherapeutics

The Incidence of Japanese Encephalitis in Taiwan—A Population-Based Study

(2014) Li-Ching Hsu et al.   PLoS Neglected Tropical Diseases

Programmed Ribosomal Frameshift Alters Expression of West Nile Virus Genes and Facilitates Virus Replication in Birds and Mosquitoes

(2014) Ezequiel Balmori Melian et al.   PLoS Pathogens

A Molecularly Cloned, Live-Attenuated Japanese Encephalitis Vaccine SA14-14-2 Virus: A Conserved Single Amino Acid in the ij Hairpin of the Viral E Glycoprotein Determines Neurovirulence in Mice

(2014) Sang-Im Yun et al.   PLoS Pathogens

Estimation of the Impact of a Japanese Encephalitis Immunization Program with Live, Attenuated SA 14-14-2 Vaccine in Nepal

(2013) Shyam Raj Upreti et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Dengue Virus and Japanese Encephalitis Virus Epidemiological Shifts in Nepal: A Case of Opposing Trends

(2013) Shyam P. Dumre et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

WHO working group on the quality, safety and efficacy of Japanese encephalitis vaccines (live attenuated) for human use, Bangkok, Thailand, 21–23 February 2012

(2013) Dennis W. Trent et al.   BIOLOGICALS

Phase III Clinical Trials Comparing the Immunogenicity and Safety of the Vero Cell-Derived Japanese Encephalitis Vaccine Encevac with Those of Mouse Brain-Derived Vaccine by Using the Beijing-1 Strain

(2013) Chiaki Miyazaki et al.   Clinical and Vaccine Immunology

Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years — India, 2013 and updates on immunization

(2013) Vipin M. Vashishtha et al.   INDIAN PEDIATRICS

Molecular Detection and Genotyping of Japanese Encephalitis Virus in Mosquitoes during a 2010 Outbreak in the Republic of Korea

(2013) Hyun-Ji Seo et al.   PLoS One

Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: A two-year follow-up study

(2013) Elina O. Erra et al.   VACCINE

Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children

(2013) Emmanuel Feroldi et al.   Human Vaccines & Immunotherapeutics

The Effect of Vaccination Coverage and Climate on Japanese Encephalitis in Sarawak, Malaysia

(2013) Daniel E. Impoinvil et al.   PLoS Neglected Tropical Diseases

Phylogeography of Japanese Encephalitis Virus: Genotype Is Associated with Climate

(2013) Amy J. Schuh et al.   PLoS Neglected Tropical Diseases

Review of Climate, Landscape, and Viral Genetics as Drivers of the Japanese Encephalitis Virus Ecology

(2013) Guillaume Le Flohic et al.   PLoS Neglected Tropical Diseases

A Single Dose of Vero Cell-Derived Japanese Encephalitis (JE) Vaccine (Ixiaro) Effectively Boosts Immunity in Travelers Primed With Mouse Brain-Derived JE Vaccines

(2012) E. O. Erra et al.   CLINICAL INFECTIOUS DISEASES

Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against Circulating Heterologous JE Virus Genotypes

(2012) Elina O. Erra et al.   CLINICAL INFECTIOUS DISEASES

A single nucleotide mutation in NS2A of Japanese encephalitis-live vaccine virus (SA14-14-2) ablates NS1' formation and contributes to attenuation

(2012) Q. Ye et al.   JOURNAL OF GENERAL VIROLOGY

Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine

(2012) Tabitha Woolpert et al.   VACCINE

An economic evaluation of the use of Japanese encephalitis vaccine in the expanded program of immunization of Guizhou province, China

(2012) Zundong Yin et al.   VACCINE

Modelling the long-term persistence of neutralizing antibody in adults after one dose of live attenuated Japanese encephalitis chimeric virus vaccine

(2012) Kamal Desai et al.   VACCINE

Safety and immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (Inactivated) (JEBIK®V) in children

(2012) Kenji Okada et al.   VACCINE

Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated)

(2012) Akiko Kikukawa et al.   VACCINE

Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12–18 months: Randomized, controlled phase 3 immunogenicity and safety trial

(2012) Emmanuel Feroldi et al.   Human Vaccines & Immunotherapeutics

Partially Neutralizing Potency against Emerging Genotype I Virus among Children Received Formalin-Inactivated Japanese Encephalitis Virus Vaccine

(2012) Yi-Chin Fan et al.   PLoS Neglected Tropical Diseases

Effectiveness of the Viet Nam Produced, Mouse Brain-Derived, Inactivated Japanese Encephalitis Vaccine in Northern Viet Nam

(2012) Florian Marks et al.   PLoS Neglected Tropical Diseases

Encephalitis temporally associated with live attenuated Japanese encephalitis vaccine: four case reports

(2011) Na Jia et al.   BMC INFECTIOUS DISEASES

Estimated global incidence of Japanese encephalitis:

(2011) Grant Campbell et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine

(2011) Peter E Nasveld et al.   Human vaccines & immunotherapeutics

Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine

(2011) Peter E. Nasveld et al.   Human vaccines & immunotherapeutics

Molecular phylogenetic and evolutionary analyses of Muar strain of Japanese encephalitis virus reveal it is the missing fifth genotype

(2011) Manal A.F. Mohammed et al.   INFECTION GENETICS AND EVOLUTION

Emergence of Genotype I of Japanese Encephalitis Virus as the Dominant Genotype in Asia

(2011) X.-L. Pan et al.   JOURNAL OF VIROLOGY

The Spatial Heterogeneity between Japanese Encephalitis Incidence Distribution and Environmental Variables in Nepal

(2011) Daniel E. Impoinvil et al.   PLoS One

Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China

(2011) Xinyu Liu et al.   VACCINE

Comparison of viral glycosylation using lectin blotting with Vero cell-derived and mouse brain-derived Japanese encephalitis vaccines

(2011) Hiroko Toriniwa et al.   VACCINE

Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51

(2011) Susanne Eder et al.   VACCINE

Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO®) induced neutralizing antibody titers

(2011) Yvonne Van Gessel et al.   VACCINE

Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: A case–control study

(2011) Charung Muangchana et al.   VACCINE

Emergence of Japanese encephalitis virus genotype V in the Republic of Korea

(2011) Ratree Takhampunya et al.   Virology Journal

Genotype V Japanese Encephalitis Virus Is Emerging

(2011) Ming-Hua Li et al.   PLoS Neglected Tropical Diseases

Risk factors for Japanese encephalitis: a case-control study

(2010) W. LIU et al.   EPIDEMIOLOGY AND INFECTION

Safety and Immunogenicity of a Single Administration of Live-attenuated Japanese Encephalitis Vaccine in Previously Primed 2- to 5-year-olds and Naive 12- to 24-month-olds

(2010) Kulkanya Chokephaibulkit et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

A decade of Japanese encephalitis surveillance in Sarawak, Malaysia: 1997-2006

(2010) See C. Wong et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Immunogenicity of an inactivated Japanese encephalitis vaccine (JE-VAX) in humans over 20 years at USAMRIID: Using PRNT50 as an endpoint for immunogenicity

(2010) Ronald B. Reisler et al.   VACCINE

Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO®, IC51

(2010) Katrin Dubischar-Kastner et al.   VACCINE

A cost–effectiveness analysis of Japanese encephalitis vaccine in Cambodia

(2010) Sok Touch et al.   VACCINE

Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials

(2010) Joseph Torresi et al.   VACCINE

Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities

(2010) Yongxin Yu   VACCINE

Molecular epidemiology of Japanese encephalitis virus circulating in South Korea, 1983-2005

(2010) Seok-Min Yun et al.   Virology Journal

Genetic analysis of strains of Japanese Encephalitis Virus isolated from swine in central China

(2010) Jian-Ming Fan et al.   VIRUS GENES

The relationship between mosquito abundance and rice field density in the Republic of Korea

(2010) Erin E Richards et al.   International Journal of Health Geographics

NS1' of Flaviviruses in the Japanese Encephalitis Virus Serogroup Is a Product of Ribosomal Frameshifting and Plays a Role in Viral Neuroinvasiveness

(2009) E. B. Melian et al.   JOURNAL OF VIROLOGY

Effectiveness of One Dose of SA 14-14-2 Vaccine against Japanese Encephalitis

(2009) Rashmi Kumar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: A randomized, observer-blind, controlled Phase 3 study

(2009) Elisabeth Schuller et al.   VACCINE

Molecular epidemiology of Japanese encephalitis in East Asia

(2009) Kouichi Morita   VACCINE

Immunogenicity and safety of IXIARO® (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age

(2009) A. Kaltenböck et al.   VACCINE

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses

(2009) Bruno Guy et al.   VACCINE

A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: Immunogenicity and anamnestic responses

(2008) Young Mo Sohn et al.   VACCINE

Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51

(2008) E. Schuller et al.   VACCINE

Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51

(2008) Elisabeth Schuller et al.   VACCINE

Cost-effectiveness of Japanese encephalitis (JE) immunization in Bali, Indonesia

(2008) Wei Liu et al.   VACCINE

Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines – Report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies

(2007) Morag Ferguson et al.   BIOLOGICALS